118 related articles for article (PubMed ID: 25163817)
1. Selection of macrolide-resistant Campylobacter in pigs treated with macrolides.
Usui M; Uchida I; Tamura Y
Vet Rec; 2014 Nov; 175(17):430. PubMed ID: 25163817
[No Abstract] [Full Text] [Related]
2. Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
Juntunen P; Olkkola S; Hänninen ML
Vet Microbiol; 2011 Jun; 150(3-4):322-30. PubMed ID: 21397412
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in Campylobacter coli selected by tylosin treatment at a pig farm.
Juntunen P; Heiska H; Olkkola S; Myllyniemi AL; Hänninen ML
Vet Microbiol; 2010 Nov; 146(1-2):90-7. PubMed ID: 20684867
[TBL] [Abstract][Full Text] [Related]
4. Erythromycin resistance of Campylobacter isolates from pigs.
Davies P; Morrow M; Funk J; Deen J
Vet Rec; 1996 Sep; 139(10):244. PubMed ID: 8883355
[No Abstract] [Full Text] [Related]
5. Development of macrolide-resistant Campylobacter in broilers administered subtherapeutic or therapeutic concentrations of tylosin.
Ladely SR; Harrison MA; Fedorka-Cray PJ; Berrang ME; Englen MD; Meinersmann RJ
J Food Prot; 2007 Aug; 70(8):1945-51. PubMed ID: 17803155
[TBL] [Abstract][Full Text] [Related]
6. Reduced antibiotic resistance to fluoroquinolones and streptomycin in 'animal-friendly' pig fattening farms in Switzerland.
Regula G; Stephan R; Danuser J; Bissig B; Ledergerber U; Lo Fo Wong D; Stärk KD
Vet Rec; 2003 Jan; 152(3):80-1. PubMed ID: 12570311
[No Abstract] [Full Text] [Related]
7. Prevalence of resistance to 11 antimicrobials among Campylobacter coill isolated from pigs on 80 grower-finisher farms in Ontario.
Varela NP; Friendship R; Dewey C
Can J Vet Res; 2007 Jul; 71(3):189-94. PubMed ID: 17695593
[TBL] [Abstract][Full Text] [Related]
8. Effects of fluoroquinolone treatment and group housing of pigs on the selection and spread of fluoroquinolone-resistant Campylobacter.
Usui M; Sakemi Y; Uchida I; Tamura Y
Vet Microbiol; 2014 Jun; 170(3-4):438-41. PubMed ID: 24629774
[TBL] [Abstract][Full Text] [Related]
9. Clinical herd health, farm management and antimicrobial resistance in Campylobacter coli on finishing pig farms in Switzerland.
Schuppers ME; Stephan R; Ledergerber U; Danuser J; Bissig-Choisat B; Stärk KD; Regula G
Prev Vet Med; 2005 Jul; 69(3-4):189-202. PubMed ID: 15907569
[TBL] [Abstract][Full Text] [Related]
10. Macrolide-resistant Campylobacter: the meat of the matter.
Belanger AE; Shryock TR
J Antimicrob Chemother; 2007 Oct; 60(4):715-23. PubMed ID: 17704515
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance of Campylobacter coli isolates from swine.
Ekkapobyotin C; Padungtod P; Chuanchuen R
Int J Food Microbiol; 2008 Dec; 128(2):325-8. PubMed ID: 18945505
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and patterns of antimicrobial resistance in Campylobacter spp isolated from pigs reared under antimicrobial-free and conventional production methods in eight states in the Midwestern United States.
Rollo SN; Norby B; Bartlett PC; Scott HM; Wilson DL; Fajt VR; Linz JE; Bunner CE; Kaneene JB; Huber JC
J Am Vet Med Assoc; 2010 Jan; 236(2):201-10. PubMed ID: 20074013
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel fosXCC gene conferring fosfomycin resistance in Campylobacter.
Wang Y; Yao H; Deng F; Liu D; Zhang Y; Shen Z
J Antimicrob Chemother; 2015 Apr; 70(4):1261-3. PubMed ID: 25433007
[No Abstract] [Full Text] [Related]
14. Isolation and antimicrobial susceptibility of Campylobacter coli and Campylobacter jejuni from slaughter hogs.
Hariharan H; Wright T; Long JR
Microbiologica; 1990 Jan; 13(1):1-6. PubMed ID: 2308529
[TBL] [Abstract][Full Text] [Related]
15. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens.
Lin J; Yan M; Sahin O; Pereira S; Chang YJ; Zhang Q
Antimicrob Agents Chemother; 2007 May; 51(5):1678-86. PubMed ID: 17353243
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics.
Kurinčič M; Klančnik A; Smole Možina S
Int J Antimicrob Agents; 2012 Nov; 40(5):467-71. PubMed ID: 22999765
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic heterogeneity of Campylobacter coli within individual pigs at farm and slaughter in the US.
Thakur S; Gebreyes WA
Zoonoses Public Health; 2010 Nov; 57 Suppl 1():100-6. PubMed ID: 21083823
[TBL] [Abstract][Full Text] [Related]
18. Repeated therapeutic dosing selects macrolide-resistant Campylobacter spp. in a turkey facility.
Logue CM; Danzeisen GT; Sherwood JS; Thorsness JL; Mercier BM; Axtman JE
J Appl Microbiol; 2010 Oct; 109(4):1379-88. PubMed ID: 20497488
[TBL] [Abstract][Full Text] [Related]
19. Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs.
Aarestrup FM; Carstensen B
Microb Drug Resist; 1998; 4(4):307-12. PubMed ID: 9988049
[TBL] [Abstract][Full Text] [Related]
20. A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production.
Alban L; Nielsen EO; Dahl J
Prev Vet Med; 2008 Feb; 83(2):115-29. PubMed ID: 17659797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
